Medical Equipment

Skin Biopsy Market Projected To Surpass $2.73 Billion By 2030 At 8% CAGR

May 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Skin Biopsy Market By 2030?

The skin biopsy market has experienced significant growth in recent years. It is projected to expand from $1.86 billion in 2025 to $2.02 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. This historical development can be attributed to an increase in skin cancer incidence, the expansion of dermatology clinics, the adoption of outpatient diagnostics, the widespread availability of biopsy instruments, and a greater awareness of early diagnosis.

The skin biopsy market size is expected to experience significant growth in the upcoming years. It is forecast to grow to $2.74 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.0%. This expansion during the forecast period is attributed to the increasing instances of melanoma, the growing adoption of AI-enabled diagnostics, the broader reach of tele-dermatology, the aging global population, and the growth witnessed in cosmetic dermatology. Key trends for the forecast period include the rise of minimally invasive biopsy techniques, an expansion in dermatology diagnostics, a preference for punch and shave biopsies, the increasing number of outpatient diagnostic procedures, and the integration of AI-assisted pathology.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28330&type=smp

Which Core Factors Are Supporting The Expansion Of The Skin Biopsy Market?

Increasing Healthcare Spending Drives Growth in the Skin Biopsy Market Growing healthcare expenditure is anticipated to support the expansion of the skin biopsy market in the coming years. Healthcare expenditure encompasses the overall spending on medical services, treatments, healthcare infrastructure, research activities, and public health programs aimed at improving health outcomes. The rise in healthcare spending is primarily linked to the increasing incidence of chronic diseases that demand ongoing and expensive medical care. Higher healthcare investments are encouraging the adoption of skin biopsy procedures by improving access to advanced diagnostic technologies and broadening dermatology-related services. This facilitates early detection and precise diagnosis of skin conditions, contributing to improved patient care and greater healthcare efficiency. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure increased by 5.6% in nominal terms in 2023, representing 0.9% higher growth compared to 2022. Therefore, increasing healthcare expenditure is fueling the growth of the skin biopsy market.

What Are The Major Segment Categories Within The Skin Biopsy Market?

The skin biopsy market covered in this report is segmented –

1) By Type Of Biopsy: Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy

2) By Application: Dermatology, Oncology, Clinical Research

3) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Dermatology Clinics

Subsegments:

1) By Excisional Biopsy: Full-Thickness Excision, Elliptical Excision

2) By Incisional Biopsy: Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy

3) By Punch Biopsy: 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (≥) 5 Millimeter (mm) Punch

4) By Shave Biopsy: Tangential Shave, Saucerization Shave, Curved Blade Shave

What Trends Are Affecting The Skin Biopsy Market Dynamics?

Leading companies in the skin biopsy market are concentrating on developing advanced solutions, such as semi-automatic biopsy instruments, to improve diagnostic accuracy and the quality of tissue samples. These semi-automatic instruments are engineered to facilitate controlled and precise tissue collection, thereby increasing the likelihood of an accurate diagnosis and enabling pathologists to conduct comprehensive tests. For example, in May 2023, Argon Medical Devices, a US-based company supplying interventional and oncology device solutions, introduced the SuperCore Advantage Semi-Automatic Biopsy Instrument. This device delivers a superior volume of tissue and is available in a complete array of lengths and gauge sizes to suit various clinical applications. It is a disposable, next-generation product, designed with insights from healthcare professionals to meet clinical needs. The SuperCore Advantage enables physicians to confidently collect more tissue, supports precise and reliable biopsies, and complements Argon’s existing product range, which includes the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This introduction solidifies Argon’s position as a key provider of soft tissue biopsy devices while simultaneously enhancing outcomes for patients.

Who Are The Companies Shaping The Skin Biopsy Market Landscape?

Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex

Access The Complete Skin Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Which Region Is The Primary Market For The Skin Biopsy Market?

North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Skin Biopsy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Browse Through More Reports Similar to the Global Skin Biopsy Market 2026, By The Business Research Company

Liquid Biopsy Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Medical Skin Markers Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-skin-markers-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795